Skip to content

Clinical research for relationship between serum IL-31 and pruritus in patients who undergo hemodialysis

Clinical research for relationship between serum IL-31 and pruritus in patients who undergo hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1080224513
Enrollment
100
Registered
2019-01-11
Start date
2018-10-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis

Interventions

Sponsors

Chugai Pharmaceutical Co., Ltd.
Lead Sponsor
Shinrakuen Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Personally provided written informed consent for the clinical study and able to comply with the requirements of the study protocol - Aged =>20 and <75 years old at the time of informed consent - Has undergone hemodialysis (including hemodiafiltration) 3 times a week for at least 12 weeks before enrollment

Exclusion criteria

Exclusion criteria: - Deemed unsuitable as a subject in the study by the investigator for some other reason

Design outcomes

Primary

MeasureTime frame
exploratory -

Secondary

MeasureTime frame
exploratory -

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026